Depot Medroxyprogesterone Acetate and Breast Cancer
- 1 September 1996
- journal article
- review article
- Published by Springer Nature in Drug Safety
- Vol. 15 (3) , 212-218
- https://doi.org/10.2165/00002018-199615030-00006
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Depot medroxyprogesterone acetate and breast cancer. A pooled analysis of the World Health Organization and New Zealand studiesJAMA, 1995
- Transient Increase in the Risk of Breast Cancer after Giving BirthNew England Journal of Medicine, 1994
- Depot-medroxyprogesterone acetate, other injectable contraceptives, and cervical neoplasiaContraception, 1994
- Breast cancer and depot-medroxyprogesterone acetate: A reviewContraception, 1994
- Depot-medroxyprogesterone acetate (DMPA) and cancer of the endometrium and ovaryContraception, 1994
- Depot medroxyprogesterone (Depo-Provera) and risk of breast cancer.BMJ, 1989
- Short term increase in risk of breast cancer after full term pregnancy.BMJ, 1988
- SUBGROUP ANALYSISThe Lancet, 1988
- A CASE-CONTROL STUDY OF BREAST-CANCER AND HORMONAL CONTRACEPTION IN COSTA-RICA1987
- The association of depo-medroxyprogesterone acetate and breast cancerContraception, 1980